Acutus is rolling out the AcQCross Qx left-heart access system for use with Boston Scientific’s TruSeal and FXD delivery systems for its Watchman left-atrial appendage closure devices.
In February 2022, the US Food and Drug Administration cleared the latest model of AcQCross Qx as an integrated transseptal dilator/needle designed to puncture the interatrial septum and allow...